Submission Details
| 510(k) Number | K090105 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | January 15, 2009 |
| Decision Date | December 30, 2010 |
| Days to Decision | 714 days |
| Submission Type | Traditional |
| Review Panel | Hematology (HE) |
| Summary | Summary PDF |
K090105 is an FDA 510(k) clearance for the LUPOTEK KCT, a Test, Time, Partial Thromboplastin (Class II — Special Controls, product code GGW), submitted by R2 Diagnostics, Inc. (South Bend, US). The FDA issued a Cleared decision on December 30, 2010, 714 days after receiving the submission on January 15, 2009. This device falls under the Hematology review panel. Regulated under 21 CFR 864.7925.
| 510(k) Number | K090105 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | January 15, 2009 |
| Decision Date | December 30, 2010 |
| Days to Decision | 714 days |
| Submission Type | Traditional |
| Review Panel | Hematology (HE) |
| Summary | Summary PDF |
| Product Code | GGW — Test, Time, Partial Thromboplastin |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 864.7925 |